FORMULATION, KIT AND A PHARMACEUTICAL COMPOSITION CONTAINING DECITABINE DERIVATIVES, PRODUCTION AND USE THEREOF Russian patent published in 2016 - IPC A61K47/10 A61K9/00 A61K9/19 A61K31/7068 A61K47/20 A61P35/00 

Abstract RU 2605289 C2

FIELD: medicine.

SUBSTANCE: series of inventions relates to medicine. Derivatives of decitabine with superior chemical stability and shelf life, with similar physiological activity are described. Methods for treating one or more myelodysplastic syndromes, leukemia, or solid tumours using the formulations are described. Derivatives of decitabine are provided in a non-aqueous formulation, which further stabilizes the derivatives.

EFFECT: derivatives of decitabine are described.

34 cl, 4 dwg, 5 tbl, 4 ex

Similar patents RU2605289C2

Title Year Author Number
DRUG COMBINATIONS 2014
  • Azab Mokhammad
  • Taverna Petro
  • Kovre Alessiya
  • Koral Sandra
RU2708246C2
LYOPHILIZED PHARMACEUTICAL COMPOSITIONS 2016
  • Joshi-Hangal, Rajashree
  • Redkar, Sanjeev
RU2723590C2
POLYMORPHS OF KINASE INHIBITOR 2012
  • Zhen Pinda
  • Martin Majkl
RU2636588C2
COMBINATION THERAPIES FOR THE TREATMENT OF CANCER 2016
  • Birss, Devid, Dzh.
  • Uorner, Stiven, L.
  • Siddikvi-Dzhain, Adam
  • Uotkott, Klifford, Dzh.
  • Kim, Vontak
RU2759963C2
LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM 2017
  • Wessels Peter
  • Tiemessen Henricus
  • De Marco Paolo
  • Larabi Malika
  • Schiedel Christiane
  • Gurina Marina
RU2756755C2
PHARMACEUTICAL COMPOUND 2018
  • Rider, Majkl
  • Uilsher, Nikola Elizabet
  • Sonders, Mark Genri
  • Baguli, Pol Entoni
  • Lindli, Kolin Tomas
  • Melling, Robert Krejg
  • Adamchik, Bozhena Eva
  • Skarati, Mirka
RU2786994C2
DRUG DELIVERY SYSTEMS BASED ON MAYTANSINOID 2018
  • Kratz, Felix
  • Abu Ajaj, Khalid
  • Warnecke, Anna
  • Nollmann, Friederike I.
  • Koester, Stephan David
  • Garcia Fernandez, Javier
  • Pes, Lara
  • Walter, Heidi-Kristin
  • Magnusson, Johannes Pall
  • Chercheja, Serghei
  • Perez Galan, Patricia
  • Medda, Federico
  • Daum, Steffen Josef
RU2783076C2
COMBINATION INCLUDING AT LEAST ONE SPLICEOSOME MODULATOR AND AT LEAST ONE INHIBITOR SELECTED FROM BCL2 INHIBITORS, BCL2/BCLXL INHIBITORS, AND BCLXL INHIBITORS, AS WELL AS APPLICATION METHODS 2018
  • Aird, Daniel
  • Corson, Laura
  • Zhu, Ping
  • Warmuth, Markus
  • Buonamici, Silvia
  • Smith, Peter Gerard
  • Fekkes, Peter
RU2783239C2
ALBUMIN-BINDING PRODRUGS BASED ON AURISTATIN E DERIVATIVES 2018
  • Kratz, Felix
  • Abu Ajaj, Khalid
  • Warnecke, Anna
  • Nollmann, Friederike I.
  • Koester, Stephan David
  • Garcia Fernandez, Javier
  • Pes, Lara
  • Walter, Heidi-Kristin
  • Magnusson, Johannes Pall
  • Chercheja, Serghei
  • Perez Galan, Patricia
  • Medda, Federico
  • Daum, Steffen Josef
RU2795101C2
BENZIMIDAZOLYLPYRIDYL ESTER COMPOUNDS 2007
  • Khashash Akhmad
  • Ritchi Shon
  • Lin' Kanvehn'
  • Shehn' Pehn
  • Okamejf Ogastus
  • Gullapalli Rampurna
RU2452469C2

RU 2 605 289 C2

Authors

Dzhoshi-Khangal Radzhashri

Tang Chunlin

Redkar Sandzhiv

Ravivarapu Kharish

Dates

2016-12-20Published

2012-08-29Filed